Stocks to Watch:

Novartis

Yahoo Finance
Novartis
‘A receptiosist sits in the front office of Novartis in Mumbai, India, Monday, April 1, 2013. India's Supreme Court on Monday rejected drug maker Novartis AG's attempt to patent a new version of a cancer drug Glivec, in a landmark decision that healthcare activists say ensures poor patients around the world will get continued access to cheap versions of lifesaving medicines. (AP Photo/Rafiq Maqbool)
View Comments (0)